azapetine

Azapetine is a benzazepine derivative and small molecule drug that acts as an alpha-1 adrenoceptor antagonist. It functions primarily as a potent arterial vasodilator and has been used in the treatment of peripheral vascular diseases. Its mechanism of action involves blocking alpha-1 adrenergic receptors on vascular smooth muscle, leading to vasodilation and improved blood flow in affected tissues[1][2][3][4][5]. The drug was marketed under the brand name Ilidar and was first launched for clinical use in 1954 for peripheral vascular disease[1].

Brand names

Ilidar

Other names

azapetineIlidar BaseAzapetina6-Allyl-6,7-dihydro-5H-dibenz(c,e)azepine